200 related articles for article (PubMed ID: 20554721)
1. Novel PET probes specific for deoxycytidine kinase.
Shu CJ; Campbell DO; Lee JT; Tran AQ; Wengrod JC; Witte ON; Phelps ME; Satyamurthy N; Czernin J; Radu CG
J Nucl Med; 2010 Jul; 51(7):1092-8. PubMed ID: 20554721
[TBL] [Abstract][Full Text] [Related]
2. Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.
Lee JT; Campbell DO; Satyamurthy N; Czernin J; Radu CG
J Nucl Med; 2012 Feb; 53(2):275-80. PubMed ID: 22302964
[TBL] [Abstract][Full Text] [Related]
3. Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway.
Schwarzenberg J; Radu CG; Benz M; Fueger B; Tran AQ; Phelps ME; Witte ON; Satyamurthy N; Czernin J; Schiepers C
Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):711-21. PubMed ID: 21127859
[TBL] [Abstract][Full Text] [Related]
4. [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.
Kim W; Le TM; Wei L; Poddar S; Bazzy J; Wang X; Uong NT; Abt ER; Capri JR; Austin WR; Van Valkenburgh JS; Steele D; Gipson RM; Slavik R; Cabebe AE; Taechariyakul T; Yaghoubi SS; Lee JT; Sadeghi S; Lavie A; Faull KF; Witte ON; Donahue TR; Phelps ME; Herschman HR; Herrmann K; Czernin J; Radu CG
Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4027-32. PubMed ID: 27035974
[TBL] [Abstract][Full Text] [Related]
5. Human Biodistribution and Radiation Dosimetry of
Barrio MJ; Spick C; Radu CG; Lassmann M; Eberlein U; Allen-Auerbach M; Schiepers C; Slavik R; Czernin J; Herrmann K
J Nucl Med; 2017 Mar; 58(3):374-378. PubMed ID: 27811125
[No Abstract] [Full Text] [Related]
6. Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography.
Laing RE; Walter MA; Campbell DO; Herschman HR; Satyamurthy N; Phelps ME; Czernin J; Witte ON; Radu CG
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2847-52. PubMed ID: 19196993
[TBL] [Abstract][Full Text] [Related]
7. The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation.
Zhang Y; Secrist JA; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):133-9. PubMed ID: 16421443
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
[TBL] [Abstract][Full Text] [Related]
9. A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs.
Likar Y; Zurita J; Dobrenkov K; Shenker L; Cai S; Neschadim A; Medin JA; Sadelain M; Hricak H; Ponomarev V
J Nucl Med; 2010 Sep; 51(9):1395-403. PubMed ID: 20810757
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics strategy reveals subpopulation of liposarcomas sensitive to gemcitabine treatment.
Braas D; Ahler E; Tam B; Nathanson D; Riedinger M; Benz MR; Smith KB; Eilber FC; Witte ON; Tap WD; Wu H; Christofk HR
Cancer Discov; 2012 Dec; 2(12):1109-17. PubMed ID: 23230188
[TBL] [Abstract][Full Text] [Related]
11. Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.
Nagai S; Takenaka K; Nachagari D; Rose C; Domoney K; Sun D; Sparreboom A; Schuetz JD
Cancer Res; 2011 Mar; 71(5):1781-91. PubMed ID: 21245102
[TBL] [Abstract][Full Text] [Related]
12. Deoxycytidine kinase augments ATM-Mediated DNA repair and contributes to radiation resistance.
Bunimovich YL; Nair-Gill E; Riedinger M; McCracken MN; Cheng D; McLaughlin J; Radu CG; Witte ON
PLoS One; 2014; 9(8):e104125. PubMed ID: 25101980
[TBL] [Abstract][Full Text] [Related]
13. Comparative Analysis of Human Nucleoside Kinase-Based Reporter Systems for PET Imaging.
Lee JT; Zhang H; Moroz MA; Likar Y; Shenker L; Sumzin N; Lobo J; Zurita J; Collins J; van Dam RM; Ponomarev V
Mol Imaging Biol; 2017 Feb; 19(1):100-108. PubMed ID: 27393689
[TBL] [Abstract][Full Text] [Related]
14. Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography.
Murphy JM; Armijo AL; Nomme J; Lee CH; Smith QA; Li Z; Campbell DO; Liao HI; Nathanson DA; Austin WR; Lee JT; Darvish R; Wei L; Wang J; Su Y; Damoiseaux R; Sadeghi S; Phelps ME; Herschman HR; Czernin J; Alexandrova AN; Jung ME; Lavie A; Radu CG
J Med Chem; 2013 Sep; 56(17):6696-708. PubMed ID: 23947754
[TBL] [Abstract][Full Text] [Related]
15. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
[TBL] [Abstract][Full Text] [Related]
16. Melatonin overcomes resistance to clofarabine in two leukemic cell lines by increased expression of deoxycytidine kinase.
Yamanishi M; Narazaki H; Asano T
Exp Hematol; 2015 Mar; 43(3):207-14. PubMed ID: 25461250
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2- fluoro-beta-D-arabinofuranosyl)adenine, 2-chloro-9-(2-deoxy-2-fluoro- beta-D-ribofuranosyl)adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro- beta-D-ribofuranosyl)adenine in CEM cells.
Parker WB; Shaddix SC; Rose LM; Shewach DS; Hertel LW; Secrist JA; Montgomery JA; Bennett LL
Mol Pharmacol; 1999 Mar; 55(3):515-20. PubMed ID: 10051535
[TBL] [Abstract][Full Text] [Related]
18. Chiral discrimination of 2'-deoxy-L-cytidine and L-nucleotides by mouse deoxycytidine kinase: low stereospecificities for substrates and effectors.
Tomikawa A; Kohgo S; Ikezawa H; Iwanami N; Shudo K; Kawaguchi T; Saneyoshi M; Yamaguchi T
Biochem Biophys Res Commun; 1997 Oct; 239(1):329-33. PubMed ID: 9345319
[TBL] [Abstract][Full Text] [Related]
19. Activation of deoxycytidine kinase by various nucleoside analogues.
Spasokoukotskaja T; Sasvári-Székely M; Hullán L; Albertioni F; Eriksson S; Staub M
Adv Exp Med Biol; 1998; 431():641-5. PubMed ID: 9598144
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]